Magazine Article | February 1, 2019

Trial By Media — Another Cost For Biopharma To Calculate?

Source: Life Science Leader

By Rob Wright, Chief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL

This month’s cover feature began on Feb. 27, 2017. I remember it so specifically because it was on that day that I first met Joaquin Duato, vice chairman of the executive committee for Johnson & Johnson. He had just spoke at the Conference Forum’s 2018 R&D Leadership Summit, a private event primarily for senior-level R&D executives from mid to large biopharmaceutical companies, and afterward I went up to introduce myself. But as I approached, I could see he was in discomfort. So, before handing him my business card, I asked if he was OK. He assured he was, revealing he had recently hurt his back while playing tennis. But that pain didn’t prevent him from honoring his commitment as a speaker. Further, it didn’t preclude him from bending down, albeit gingerly, to fish out a business card from his well-worn briefcase. It was this exchange that eventually led to the article on how J&J approaches partnering, which you can read about on p. 22.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: